Search

Kumar, Ambuj, and Rituraj Purohit. 2014. “Use of Long Term Molecular Dynamics Simulation in Predicting Cancer Associated SNPs.”. PLoS Computational Biology 10 (4): e1003318.

Mhaskar, Rahul, Vaibhav Alandikar, Patricia Emmanuel, Benjamin Djulbegovic, Sangita Patel, Atul Patel, Eknath Naik, Shyam Mohapatra, and Ambuj Kumar. 2013. “Adherence to Antiretroviral Therapy in India: A Systematic Review and Meta-Analysis.”. Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine 38 (2): 74-82.

Potluri, Venkat Sumanth, Julio Sokolich, Jacentha Buggs, William McClellan, Ebonie Rogers, Kristina Barber, Kristal Cocuy, Ambuj Kumar, and Victor Bowers. 2019. “Outcomes in Hepatocellular Carcinoma Liver Transplantation before and After the Mandated Six-Month Wait Time.”. The American Surgeon 85 (8): 900-903.

Gulati, Gavish, Krutika Satish Gaonkar, Balu Kamraj, Ambuj Kumar, and Rituraj Purohit. 2012. “Structure Based Energy Calculation to Determine the Regulation of G Protein Signalling by RGS and RGS-G Protein Interaction Specificity.”. Interdisciplinary Sciences, Computational Life Sciences 4 (3): 173-82.

Djulbegovic, Benjamin, Heloisa P Soares, and Ambuj Kumar. 2006. “What Kind of Evidence Do Patients and Practitioners Need: Evidence Profiles Based on 5 Key Evidence-Based Principles to Summarize Data on Benefits and Harms.”. Cancer Treatment Reviews 32 (7): 572-6.

Kumar, Ambuj, and Benjamin Djulbegovic. 2002. “Why Evidence Based Oncology Management.”. The Journal of Oncology Management : The Official Journal of the American College of Oncology Administrators 11 (6): 13-6.

Bapaye, Mahadev, Sanjay Kolte, Ketan Pai, Alok Godse, Ashish Pardeshi, Ashish Bhave, and Ambuj Kumar. 2003. “Jejunogastric Intussusception Presenting With Outlet Obstruction.”. Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology 22 (1): 31-2.

Soares, Heloisa P, Ambuj Kumar, and Benjamin Djulbegovic. 2006. “Evidence Profiles for Lung Cancer: Benefit/Harms Data Based on the Totality of Randomized Evidence.”. Cancer Treatment Reviews 32 (8): 652-5.